OCUGEN
Ocugen is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing transformative therapies to treat the whole eye. Our Phase 3 small molecule drug candidate for oGVHD, if approved, will be the first and only treatment for this orphan disease. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many”. And our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy.
OCUGEN
Industry:
Biopharma Biotechnology Health Care
Founded:
2013-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.ocugen.com
Total Employee:
11+
Status:
Active
Contact:
(720)859-3549
Total Funding:
190 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
Nuvation Bio
Nuvation Bio is a biopharmaceutical company.
NuCana
NuCana is a clinical-stage biopharmaceutical company
Novaremed AG
Novaremed AG is a clinical-stage Swiss biopharmaceutical company.
Vidac Pharma
Vidac is a clinical stage innovative biopharmaceutical company dedicated to discovering
Vyriad
Vyriad is a clinical stage biopharmaceutical company.
Mereo Biopharma
Mereo is a new UK-based speciality biopharmaceutical company.
MatriSys Bioscience
MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
MetrioPharm
MetrioPharm is a clinical stage pharmaceutical development company.
Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company.
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Acasti Pharma
Acasti Pharma is an emerging biopharmaceutical company.
Adrenomed
Adrenomed is a privately-financed, clinical-stage biopharmaceutical company.
Atom Bioscience & Pharmaceutical
Atom Bioscience is a clinical-stage biotechnology company.
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Aniluxx Biotechnology
Aniluxx Biotechnology is a development stage biopharmaceutical company
Aurealis Pharma
Aurealis Pharma is a biopharmaceutical company.
Avitide
Avitide develops affinity purification solutions for biopharmaceutical companies.
Sio Gene Therapies
Sio Gene Therapies is a clinical-stage biopharmaceutical company.
Avalo Therapeutics
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Ascentage Pharma
Ascentage is a clinical-stage biopharmaceutical company that develops drugs for the treatment of cancer.
EpimAb Biotherapeutics
EpimAb Biotherapeutics is a privately owned biopharmaceutical R&D company.
BlueRock Therapeutics
It is a regenerative medicine company.
Biocytogen
Biopharmaceutical company.
BirchBioMed
BirchBioMed is a clinical-stage biomedical company.
Bond Biosciences
Bond Biosciences is a biopharmaceutical company
BiondVax
BiondVax is an innovative biopharmaceutical company.
BioQ Pharma
BioQ Pharma is a late stage specialty pharmaceutical company focused on developing.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Transcode Therapeutics
TransCode Therapeutics is a pre-clinical biopharmaceutical company.
Touchlight Genetics
Touchlight Genetics, a British bio-pharmaceutical company founded in 2007.
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
UroGen Pharma
UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies.
Kangpu Biopharmaceuticals, Ltd.
Kangpu Bio-Pharma is a clinical stage company.
SELLAS Life Sciences
SELLAS Life Sciences is a late-stage biopharmaceutical company.
Strekin
Strekin AG is a clinical-stage biopharmaceutical company headquartered in Basel, Switzerland.
SAB Biotherapeutics
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
SciClone Pharmaceuticals
SciClone Pharmaceuticals is a pharmaceutical company.
Soleno Therapeutics
Soleno Therapeutics is a clinical-stage biopharmaceutical company.
Semler Scientific
Semler Scientific is an emerging medical risk-assessment company.
Samsung Bioepis
Samsung Bioepis is a biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Destiny Pharma
Destiny Pharma Ltd., a clinical stage pharmaceutical company
Hope Medicine
Hope Medicine is a science-driven clinical stage biopharmaceutical company
Humanetics Corporation
clinical stage pharmaceutical company.
HUTCHMED (China) Limited
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative, commercial-stage, biopharmaceutical company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
ImmunoBrain Checkpoint
ImmunoBrain Checkpoint is a biopharmaceutical company.
IconOVir Bio
IconOVir Bio is a preclinical-stage biotechnology company.
GENFIT
GENFIT is a late-stage biopharmaceutical company.
Giiant Pharma
Giiant Pharma is a preclinical-stage biotech company.
Oxeia Biopharmaceuticals
Oxeia Biopharmaceuticals is a clinical stage biotech company.
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
Ovid Therapeutics
Ovid Therapeutic's purpose is to solve intractable medical problems.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Opiant Pharmaceuticals
Opiant Pharmaceuticals is a specialty pharmaceutical company.
Cellenkos
Cellenkos is a clinical stage biotech company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Cassava Sciences
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience.
CytoVac
Cytovac is a clinical-stage biopharmaceutical company.
Caladrius Biosciences
Caladrius Biosciences is a clinical-stage biopharmaceutical company.
Peptidream
Peptidream is a biopharmaceutical company.
PharmaIN
PharmaIN is a development stage biopharmaceutical company,
PlasmaGen Biosciences
PlasmaGen Biosciences is a biopharmaceutical company .
YS Biopharma
YS Biopharma is a global, fully integrated bio-pharmaceutical company.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Kelly Beck Vice President, Investor Relations and Operations @ Ocugen
Vice President, Investor Relations and Operations
2017-07-01
Uday B. Kompella Co-Founder @ Ocugen
Co-Founder
Shankar Musunuri Chairman, CEO & Co-Founder @ Ocugen
Chairman, CEO & Co-Founder
2015-05-01
Robert J. Hopkins Chief Medical Officer @ Ocugen
Chief Medical Officer
2022-09-01
Shankar Musunuri Chairman & Co-Founder @ Ocugen
Chairman & Co-Founder
2013-09-01
Arun Upadhyay Chief Scientific Officer @ Ocugen
Chief Scientific Officer
2022-09-01
Leeladhar Sammatu Director of CMC Process development @ Ocugen
Director of CMC Process development
2021-08-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-09-30 | Histogenics | Histogenics acquired by Ocugen | N/A |
Investors List
ROTH Capital Partners
ROTH Capital Partners investment in Post-IPO Equity - Ocugen
Abdi Ibrahim Pharmaceuticals
Abdi Ibrahim Pharmaceuticals investment in Series B - Ocugen
Lancaster Group
Lancaster Group investment in Series B - Ocugen
Frank Leo
Frank Leo investment in Series B - Ocugen
John Zhang
John Zhang investment in Series B - Ocugen
Bernhard Hampl
Bernhard Hampl investment in Series A - Ocugen
Ahsan M. Nasratullah
Ahsan M. Nasratullah investment in Series A - Ocugen
EB5 Life Sciences
EB5 Life Sciences investment in Series A - Ocugen
Key Employee Changes
| Date | New article |
|---|---|
| 2022-09-01 | Ocugen Appoints Robert J. Hopkins, MD, MPH & TM, FACP, FIDSA, as Chief Medical Officer and Promotes Arun Upadhyay, PhD, to Chief Scientific Officer |
Official Site Inspections
http://www.ocugen.com Semrush global rank: 1.75 M Semrush visits lastest month: 13.48 K
- Host name: 57.82.212.35.bc.googleusercontent.com
- IP address: 35.212.82.57
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Ocugen"
About - Ocugen
Dr. Kompella is an Ocugen Co-founder and a member of the board. He is a Professor of Pharmaceutical Sciences, Ophthalmology, and Bioengineering at University of Colorado …See details»
Ocugen - Crunchbase Company Profile & Funding
Ocugen is a clinical-stage biopharmaceutical company focused on discoverinOcugen Inc is a clinical-stage biopharmaceutical business focused on discovering, developing, and commercializing gene treatments to cure blinding …See details»
Investors | Ocugen, Inc.
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer …See details»
Ocugen, Inc. (OCGN) Company Profile & Facts - Yahoo Finance
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. …See details»
Ocugen Q&A: novel gene and cell therapies - Bio.News
Aug 25, 2023 Ocugen aims to develop tailored therapies that will compensate for defective genes and improve patient outcomes.See details»
Ocugen Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Ocugen has 2 employees at their 1 location and $6.04 m in annual revenue in FY 2023. See insights on Ocugen including office locations, competitors, revenue, financials, …See details»
Our Culture - Ocugen
At Ocugen, we strive to foster a sense of community, where team members can be their genuine selves and fully contribute to our pursuit of courageous innovation. We strive for an environment where everyone knows that their …See details»
Ocugen CEO & CSO to Present at 41st Annual AAPI Convention …
Jun 30, 2023 “The AAPI is an impressive organization that fosters the continued leadership of healthcare professionals of Indian origin through educational and networking opportunities, …See details»
Ocugen - Contacts, Employees, Board Members, Advisors
Organization. Ocugen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 9. Number of Board …See details»
Ocugen - Overview, News & Similar companies | ZoomInfo.com
Ocugen to Participate in a Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference MALVERN, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or …See details»
Ocugen, Inc. Signs Letter of Intent to Acquire Vaccine …
Jan 27, 2022 The World Health Organization (WHO) recently added COVAXIN™ (BBV152) to its list of vaccines authorized for emergency use. And, as many as 110 countries have agreed to …See details»
Ocugen, Inc. Announces Health Canada Approval to Initiate Phase …
MALVERN, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, …See details»
Ocugen, Inc. Announces Removal of Clinical Hold on …
Oct 9, 2024 Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health …See details»
Ocugen, Inc. Announces Positive 2-Year Data Across Multiple …
3 days ago About Ocugen, Inc. Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that …See details»
Ocugen, Inc. Provides an Update on its Investigational New Drug ...
Nov 26, 2021 Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to …See details»
Our Partners - Ocugen
About Bharat Biotech Bharat Biotech has established an excellent track record of innovation with more than 145 global patents, a wide product portfolio of more than 16 vaccines, 4 bio …See details»
Ocugen Reports Positive Two-Year Safety and Efficacy Results
2 days ago Ocugen, Inc. Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve …See details»
Therapeutic Areas - Ocugen
Ocugen’s focus centers on finding ways to make hard-to-treat blindness diseases a thing of the past. Below are areas our researchers and collaborators are exploring to help people and …See details»
Ocugen’s COVID-19 Vaccine Co-Development Partner, Bharat …
Mar 3, 2021 For more information, please visit www.ocugen.com. About Bharat Biotech: Bharat Biotech has established an excellent track record of innovation with more than 145 global …See details»
Ocugen, Inc. Announces Positive 2-Year Data Across Multiple …
2 days ago Ocugen, Inc. Announces Positive 2-Year Data Across Multiple Mutations from Phase 1/2 Clinical Trial of OCU400 —A Novel Modifier Gene Therapy for Retinitis Pigmentosa …See details»